Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem
Chỉ hiển thị Multimedia

Canagliflozin holds promise against MAFLD in T2D patients
27 Oct 2023
bởiStephen Padilla
Patients with type 2 diabetes (T2D) who received canagliflozin benefit from improved liver biochemistry and metabolism, a recent study has shown. In addition, treatment with canagliflozin appears to confer positive effects on liver fibrosis.
27 Oct 2023

High red meat consumption increases risks of CVD and diabetes
27 Oct 2023
bởiKanas Chan
Higher consumption of both unprocessed and processed red meat is associated with higher risks of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), according to a meta-analysis involving >4.4 million people by researchers from the University of Hong Kong (HKU).
27 Oct 2023







